Please login to the form below

Not currently logged in
Email:
Password:

Dihon

This page shows the latest Dihon news and features for those working in and with pharma, biotech and healthcare.

Bayer puts research at heart of business growth

Bayer puts research at heart of business growth

This area has been boosted over the past year with the acquisition of Merck &Co's consumer health division and the takeover of China-based Dihon Pharmaceutical.

Latest news

  • Bayer completes takeover of Chinese OTC company Bayer completes takeover of Chinese OTC company

    Bayer completes takeover of Chinese OTC company. Expands consumer health presence with Dihon purchase. ... Germany's Bayer has completed its acquisition of the China-based consumer healthcare company Dihon Pharmaceutical.

  • Pharma is turning its attention to consumer healthcare Pharma is turning its attention to consumer healthcare

    The company also bought Chinese based Dihon Pharmaceuticals, which specialises in OTC medicines and traditional herbal remedies, to increase its offering and presence in Asia. “

  • Bayer raises sales predictions for new pharma products Bayer raises sales predictions for new pharma products

    Fresh from announcing a deal to buy Chinese over-the-counter drugmaker Dihon Pharmaceutical, Bayer also reported a 4 per cent sales decline for its consumer health division to 1.96bn - ... Consumer health should return to low- to mid-single-digit growth

  • Bayer buys Chinese consumer care company Bayer buys Chinese consumer care company

    Bayer buys Chinese consumer care company. Acquires Dihon Pharmaceutical as Algeta takeover closes. ... Bayer has boosted its consumer healthcare operations in emerging markets with a deal to acquire China-based Dihon Pharmaceutical Group.

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Sustainable solutions Sustainable solutions

    This was followed five months later by the smaller, but still notable, deal to acquire the Chinese consumer healthcare company Dihon Pharmaceutical for around $485m.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics